Kurly secures 33 billion won investment from Naver through third-party allocation, expanding strategic partnership as Naver's stake grows to 6.2% with funds earmarked for logistics expansion and new business development
#YonhapInfomax #Kurly #Naver #CapitalIncrease #StrategicPartnership #LogisticsExpansion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=119028ImmuneOncia raises 100 billion won through rights offering to fund NK/T cell lymphoma drug development, while major shareholder Yuhan Corp. participates with only 15 billion won investment, maintaining majority control despite stake dilution from 65.75% to 56.24%
#YonhapInfomax #ImmuneOncia #YuhanCorp #CapitalIncrease #ImmunoOncology #NK/TCellLymphoma
#Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=113762
ImmuneOncia Raises 100 Billion Won in Capital Increase, Major Shareholder Yuhan Corp. Partially Participates
ImmuneOncia raises 100 billion won through rights offering to fund NK/T cell lymphoma drug development, while major shareholder Yuhan Corp. participates with only 15 billion won investment, maintaining majority control despite stake dilution from 65.75% to 56.24%
Samsung Biologics announces 520 billion won capital injection into its U.S. subsidiary to fund acquisition of Human Genome Sciences' biopharmaceutical production facility in Rockville, Maryland, through shareholder allocation with record date set for the 27th.
#YonhapInfomax #SamsungBiologics #CapitalIncrease #HumanGenomeSciences #BiopharmaceuticalFacility #RockvilleFacility #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=111218
Samsung Biologics Injects 520 Billion Won into U.S. Subsidiary Through Capital Increase
Samsung Biologics announces 520 billion won capital injection into its U.S. subsidiary to fund acquisition of Human Genome Sciences' biopharmaceutical production facility in Rockville, Maryland, through shareholder allocation with record date set for the 27th.
GS Group invests 3 billion won in Kakao Healthcare's capital increase, securing 5-6% stake and potentially replicating their successful mobility partnership model in the healthcare sector, with total fundraising of 50 billion won expected to complete by H1 2026.
#YonhapInfomax #KakaoHealthcare #GSGroup #CapitalIncrease #StrategicPartnership #DigitalHealthcare #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=111121
GS Group Invests 3 Billion Won in Kakao Healthcare Capital Increase
GS Group invests 3 billion won in Kakao Healthcare's capital increase, securing 5-6% stake and potentially replicating their successful mobility partnership model in the healthcare sector, with total fundraising of 50 billion won expected to complete by H1 2026.
SK Ecoplant to invest 50 billion won in subsidiary SK Eco Engineering through paid-in capital increase on March 23, following last month's acquisition of all RCPS to make it a wholly-owned subsidiary, aiming to reduce financial costs and strengthen AI infrastructure capabilities.
#YonhapInfomax #SKEcoplant #SKEcoEngineering #CapitalIncrease #AIInfrastructure #FinancialCosts #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=108486
SK Ecoplant Decides to Inject 50 Billion Won into Subsidiary Eco Engineering
SK Ecoplant to invest 50 billion won in subsidiary SK Eco Engineering through paid-in capital increase on March 23, following last month's acquisition of all RCPS to make it a wholly-owned subsidiary, aiming to reduce financial costs and strengthen AI infrastructure capabilities.
KB Financial Group is injecting KRW 700 billion ($525 million) into KB Securities, marking its first major capital increase in a decade as it accelerates expansion in capital markets amid shifting financial sector trends and rising group earnings contributions from its securities arm.
#YonhapInfomax #KBFinancialGroup #KBSecurities #CapitalIncrease #ROE #KRW700Billion #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=106769
KB Financial Group Overcomes Decade-Long ROE Concerns—Commits KRW 700 Billion to Expand Securities Unit
KB Financial Group is injecting KRW 700 billion ($525 million) into KB Securities, marking its first major capital increase in a decade as it accelerates expansion in capital markets amid shifting financial sector trends and rising group earnings contributions from its securities arm.
KB Financial Group will inject KRW 700 billion ($525 million) into KB Securities via a rights offering, marking its largest capital increase for the brokerage in a decade amid a sector-wide shift of funds toward securities.
#YonhapInfomax #KBFinancialGroup #KBSecurities #CapitalIncrease #RightsOffering #MoneyMove #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=106768
Banking Sector Joins 'Money Move'—KB Securities to Receive KRW 700 Billion Capital Injection from KB Financial Group, First in a Decade
KB Financial Group will inject KRW 700 billion ($525 million) into KB Securities via a rights offering, marking its largest capital increase for the brokerage in a decade amid a sector-wide shift of funds toward securities.
Woori Financial Group will make both quarterly and year-end dividends tax-exempt from this year, aiming to boost shareholder returns, while confirming that planned capital increases at its securities unit will not impact the group’s CET1 ratio.
#YonhapInfomax #WooriFinancialGroup #TaxExemptDividends #ShareholderReturns #CET1Ratio #CapitalIncrease #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=104349
Woori Financial Group to Offer Tax-Exempt Dividends for Both Quarterly and Year-End Payouts Starting This Year
Woori Financial Group will make both quarterly and year-end dividends tax-exempt from this year, aiming to boost shareholder returns, while confirming that planned capital increases at its securities unit will not impact the group’s CET1 ratio.
Korea Investment Holdings Co. will inject 1.5 trillion won ($1.13 billion)—its largest-ever capital increase—into Korea Investment & Securities Co., strengthening the brokerage’s financial base and supporting long-term growth.
#YonhapInfomax #KoreaInvestmentHoldings #KoreaInvestmentSecurities #RightsOffering #CapitalIncrease #FinancialSoundness #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=101583
Korea Investment & Securities Launches Record 1.5 Trillion Won Rights Offering—Holding Company Injects 15% of Equity
Korea Investment Holdings Co. will inject 1.5 trillion won ($1.13 billion)—its largest-ever capital increase—into Korea Investment & Securities Co., strengthening the brokerage’s financial base and supporting long-term growth.
Shinhan Lifecare, a subsidiary of Shinhan Life Insurance, has opened its first premium nursing home, Solace Home Misa, as South Korean insurers accelerate expansion into the senior care market with major investments and new facilities.
#YonhapInfomax #ShinhanLifecare #SeniorCare #PremiumNursingHome #ShinhanLifeInsurance #CapitalIncrease #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=100197
Yonhap Infomax News